Celcuity
A Senior Medical Director at Celcuity provides medical oversight for Phase I-III oncology clinical trials, driving study design, protocol development, and regulatory compliance. The role involves collaborating with investigators and key opinion leaders to monitor trial conduct, analyze safety and efficacy data, and prepare regulatory documents. This position also leads the development of publications and manages vendor activities to support the company's targeted cancer therapies.
Headquarters
Minneapolis, Minnesota, United States
Company Size
11-50 employees
Founded
2012
Celcuity is a clinical-stage biotechnology company developing targeted therapies for multiple solid tumor indications, with a focus on breast and prostate cancers. Their lead product candidate, gedatolisib, is a pan-PI3K and mTORC1/2 inhibitor that comprehensively blockades the PI3K/AKT/mTOR (PAM) pathway. Celcuity harnesses insights into oncogenic pathways to advance therapies that disrupt cancer-driving mechanisms, operating under the tagline "Block PAM. Unlock Tomorrow."
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Celcuity.
55% above the average for this role